InvestorsHub Logo
Followers 52
Posts 4107
Boards Moderated 0
Alias Born 07/03/2005

Re: JackAskSlap post# 3502

Friday, 08/05/2022 7:39:22 AM

Friday, August 05, 2022 7:39:22 AM

Post# of 3952
One of the big names in COVID testing is languishing among its peers and might want to acquire technology that expands its depth in testing. Co-Diagnostics (NASDAQ: CODX) has a market cap of $221 million and also appears to have been working on a monkeypox test for the past couple weeks. The company is positioned with approximately $97.4 million in cash equivalents. This puts the company’s enterprise value at $125 million and their book value at $4.32/share in comparison to their stock price of $6.50. In the last quarter, they sold $22.7 million in sales and brought $9.8 million to the bottom line. Their P/E ratio is a mere 5x.

https://insiderfinancial.com/monkeypox-stocks-heating-up-the-charts-tomdf-apdn-codx/183385/

Opti

Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CODX News